Extramedullary leukemia relapse after allogeneic stem cell transplantation: a novel mechanism of immune escape?

Immunotherapy. 2020 Jun;12(9):635-640. doi: 10.2217/imt-2019-0215. Epub 2020 May 21.

Abstract

Background: Relapse is a significant cause of treatment failure after allogeneic stem cell transplantation. In many cases relapse occurs when leukemic cells escape from immune surveillance. Methods & results: In the setting of haploidentical transplantation, immune escape is usually the result of the loss of the mismatched haplotype from leukemic cells, while downregulation of HLA-expression has been postulated as a significant cause of immune escape after transplantation with the use of HLA-matched donors. We observed that patients with acute leukemia who relapse at the time of active graft-versus-host-disease, usually develop extramedullary leukemia while they remain free of leukemia in peripheral blood and bone marrow. Conclusion: Our observation points toward a novel mechanism of immune escape which is microenvironment-specific.

Keywords: allogeneic stem cell transplantation; extramedullary relapse; graft-versus-host-disease; immune escape; leukemia; tumor microenvironment.

MeSH terms

  • Adult
  • Allografts / immunology*
  • Female
  • Graft vs Host Disease / immunology*
  • Humans
  • Leukemia / immunology*
  • Leukemia / therapy*
  • Male
  • Middle Aged
  • Recurrence
  • Stem Cell Transplantation / methods*
  • Treatment Outcome